Transaction #18878 · Form 4 · 0001140361-25-045382
Vericel Corp · Exercise / conversion · Restricted Stock Unit
Vericel Corp · Transacted July 22, 2025 · Filed December 12, 2025
What does this filing report?
An SEC Form 4 filing for Vericel Corp records an exercise / conversion involving Restricted Stock Unit on July 22, 2025. The reported quantity was 2,625. The filing date is December 12, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Vericel Corp
- Company CIK
- 0000887359
- Security type
- Derivative
- Acquisition type
- Exercise / conversion · Code M
- Quantity acquired
- 2,625
- Reported price
- Not reported · See footnotes
- Reference value
- Not reported
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 7,875
- Ownership description
- Not reported
- SEC acceptance time
- Dec 12, 2025, 4:05 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Mahoney Karen ↗
Chief Human Resources Officer
CIK 0002055280
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Derivative terms
- Underlying security
- Common Stock
- Underlying quantity
- 2,625
- Conversion / exercise price
- Not reported
- Exercise date
- Not reported
- Expiration date
- Not reported
Filing footnotes & remarks
- F1
- The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on July 22, 2024. The remaining RSUs will vest in annual installments on July 22, 2026, July 22, 2027, and July 22, 2028, respectively.
- F2
- These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs.
- F3
- Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation.
- F4
- No expiration date for this type of award.
- F5
- The Fair Market Value of the vested derivative securities is $37.98 per share.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.